Gerardo Nigro
About
In The Last Decade
Gerardo Nigro
39 papers receiving 830 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 517
- Cardiology and Cardiovascular Medicine 358
- Cellular and Molecular Neuroscience 163
- Genetics 132
- Neurology 108
Countries citing papers authored by Gerardo Nigro
This map shows the geographic impact of Gerardo Nigro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Nigro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Nigro more than expected).
Fields of papers citing papers by Gerardo Nigro
This network shows the impact of papers produced by Gerardo Nigro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Nigro. The network helps show where Gerardo Nigro may publish in the future.
Co-authorship network of co-authors of Gerardo Nigro
This figure shows the co-authorship network connecting the top 25 collaborators of Gerardo Nigro. A scholar is included among the top collaborators of Gerardo Nigro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerardo Nigro. Gerardo Nigro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 29 | |
| 6 | Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results. | 10 |
| 7 | 5 | |
| 8 | Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population. | 9 |
| 9 | Novel mutations in LMNA A/C gene and associated phenotypes. | 18 |
| 10 | 22 | |
| 11 | The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. | 11 |
| 12 | Cardiac resynchronization improves heart failure in one patient with myotonic dystrophy type 1. A case report. | 17 |
| 13 | Cardiac involvement in patients with spinal muscular atrophies. | 22 |
| 14 | 32 | |
| 15 | Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation. | 8 |
| 16 | Cardiomyopathies: diagnosis of types and stages. | 6 |
| 17 | ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? | 8 |
| 18 | 13 | |
| 19 | 26 | |
| 20 | [Idiopathic left fascicular ventricular tachycardia: the evidence for a "bystander" bundle of His participation]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.